Consider the following before gently correcting your loved one: The present stage of dementia and your loved one’s ability to process information.; Is the behavior connected to dementia, or was it ...

While there is no cure for Alzheimer’s disease, nor have any disease-modifying therapies been approved yet, there are several medications available by prescription to treat disease symptoms that ...

“This is excellent news for the 3+ million Americans currently taking lithium-based treatments,” Stephan Jackman, CEO of Alzamend, said in a press release.. AL001 (also known as LiProSal) is an ionic ...

Patients with Alzheimer’s disease (AD) experience a slow progressive decline in memory and cognitive ability, among other symptoms, due to the spread of damage in the brain. Generally, the disease is ...

“This first regulatory approval for AlzoSure Predict … represents a significant advance for the millions of patients and their families in Europe at risk from Alzheimer’s disease,” Paul Kinnon, CEO of ...

The decision follows a supplemental application from Eisai, which is codeveloping Leqembi with Biogen, based on the modeling of data from the Phase 2 Study 201 (NCT01767311) and the Phase 3 Clarity AD ...

“In the care home, I really wanted Jelly Drops to tackle dehydration and also to be really fun and engaging and sort of a social tool in the care home as well,” Hornby said in a video interview with ...

Alzheimer’s disease (AD) is associated with a gradual decline in memory and mental ability, due to the accumulation and spread of damage in the brain. It is an irreversible condition, with symptoms ...

For the first time, the beneficial effects of pure maple syrup were included in the natural products that protect brain cells against the neural damage found in patients with Alzheimer’s disease. Dr.

The test, developed by Roche in collaboration with Eli Lilly, is intended to support a more accurate Alzheimer’s diagnosis in adults, ages 60 and older, when used with other clinical assessments..

Alzamend Neuro has requested approval from the U.S. Food and Drug Administration (FDA) to begin clinical trials to test AL001, its investigational lithium-based ionic cocrystal oral therapy for ...

According to a 2013 article published in Administration and Policy in Mental Health, “Public stigma is a pervasive barrier that prevents many individuals in the U.S. from engaging in mental health ...